Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Rhinosinusitis With Nasal Polyposis With Dupilumab and Mepolizumab: A Randomized, Multi-centre, Head-to-head Comparison in Real-world Danish Patients

NCT05942222 is registered in ClinicalTrials.gov with Rigshospitalet, Denmark as lead sponsor.

NCT NCT05942222
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05942222 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Rhinosinusitis With Nasal Polyposis With Dupilumab and Mepolizumab: A Randomized, Multi-centre, Head-to-head Comparison in Real-world Danish Patients
Lead sponsor
Rigshospitalet, Denmark
Phase
Phase 4
Overall status
Active, not recruiting
Start date
April 27, 2023
Completion date
May 1, 2026
Enrollment
220 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

asthma; eosinophilic, chronic rhinosinusitis with nasal polyps, eosinophilia